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Shigella  infections are responsible for an
estimated 300,000 illnesses and 600 deaths per
year in the United States and more than 600,000
deaths per year worldwide (1). Shigella species
are typically transmitted by direct or indirect
fecal-oral contact; as a result, shigellosis has long
been associated with outbreaks in day-care
centers, nursing homes, and institutionalized
populations (2-4). However, several studies have
demonstrated an increased frequency of shigello-
sis cases in young adult men residing in urban
settings who have little, if any, exposure to these
traditionally recognized risk groups (5-9). These
investigations also suggest that Shigella
infection occurs during the practice of gay sex;
however, since most of these studies occurred
before the HIV epidemic, the relationship
between HIV infection and gay sex and the
subsequent risk for shigellosis has yet to be
evaluated (5-9).
HIV-infected persons are at increased risk
for infection by several common enteric
pathogens (10). Previous investigations have
demonstrated that HIV-infected patients are at
20 times greater risk for infection with
Salmonella  species and 39 times greater risk for
infection with Campylobacter species than the
general population (11,12). To determine the
rate of shigellosis in HIV-infected persons, we
investigated all cases of shigellosis in San
Francisco, a county with a high prevalence of
HIV infection and a high incidence of shigellosis.
Alameda, a neighboring county with lower rates
of shigellosis and HIV infection, was used as a
comparison area for our investigation because of
its proximity and differing shigellosis and HIV
epidemiology.
During 1996, cases of culture-confirmed
shigellosis were identified in San Francisco and
Alameda Counties by active surveillance in 28
laboratories for isolates of Shigella species
cultured from any anatomic site as part of the
California Emerging Infections Program. The
program comprises one of five sites in the
Foodborne Diseases Active Surveillance Net-
work (FoodNet), which is part of the Centers for
Disease Control and Prevention’s Emerging
Infections Program. All available medical records
of patients were reviewed by a standardized data
collection instrument detailing demographic and
medical information. Data concerning sexual
activity and orientation and foreign travel were
obtained from routine telephone interviews of
patients with shigellosis, conducted by the San
HIV Infection as a Risk Factor
for Shigellosis
1
Jefferson T. Baer,* Duc J. Vugia,*†‡ Arthur L. Reingold Jefferson T. Baer,* Duc J. Vugia,*†‡ Arthur L. Reingold Jefferson T. Baer,* Duc J. Vugia,*†‡ Arthur L. Reingold Jefferson T. Baer,* Duc J. Vugia,*†‡ Arthur L. Reingold Jefferson T. Baer,* Duc J. Vugia,*†‡ Arthur L. Reingold         ,*§ ,*§ ,*§ ,*§ ,*§
Tomas Aragon,¶ Frederick J. Angulo,# and Tomas Aragon,¶ Frederick J. Angulo,# and Tomas Aragon,¶ Frederick J. Angulo,# and Tomas Aragon,¶ Frederick J. Angulo,# and Tomas Aragon,¶ Frederick J. Angulo,# and
Williamson Z. Bradford*§** Williamson Z. Bradford*§** Williamson Z. Bradford*§** Williamson Z. Bradford*§** Williamson Z. Bradford*§**
*California Emerging Infections Program, San Francisco, California, USA;
†California Department of Health Services, Berkeley, California, USA;
‡University of California, San Francisco, California, USA; §School of Public
Health, University of California, Berkeley, California, USA; ¶San Francisco
Department of Public Health, San Francisco, California, USA; #Centers for
Disease Control and Prevention, Atlanta, Georgia, USA; and **IntraBiotics
Pharmaceuticals, Mountain View, California, USA
Address for correspondence: Williamson Z. Bradford,
IntraBiotics Pharmaceuticals, Inc., 1255 Terra Bella Ave.,
Mountain View, CA 94080, USA; fax: 650-969-0663; e-mail:
BBradford@intrabiotics.com.
We investigated cases of shigellosis in San Francisco and Alameda Counties
identified during 1996 by active laboratory surveillance to assess the role of HIV
infection as a risk factor for shigellosis. Dramatically elevated rates of shigellosis in
HIV-infected persons implicate HIV infection as an important risk factor for shigellosis
in San Francisco.
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Table 1. Persons with shigellosis, by county of
residence, 1996
 San Francisco   Alameda
Characteristic     (n = 228)   (n = 140) p value
Male 157/228 (69%) 60/140 (43%) <0.001
Age >18 181/227 (80%) 57/140 (41%) <0.001
Race
White 117/200 (59%) 15/92 (16%) <0.001
Black   39/200 (20%) 44/92 (48%) <0.001
Hispanic   37/200 (19%) 22/92 (24%)   0.285
Hospitalized   22/201 (11%) 12/140 (9%)   0.472
HIV infection   66/168 (39%)   9/125 (7%) <0.001
Foreign travel   25/185 (14%) NAa     ---
Gay male   96/190 (51%) NAa     ---
Recent sex   70/136 (51%) NAa     ---
aNA = not available
Francisco Department of Public Health. This
information was not available for Alameda
residents because no telephone interviews were
conducted in Alameda County.
Patients were considered HIV-infected if
their medical record contained a physician’s note
or a laboratory report documenting HIV
infection. In the absence of such documentation,
patients were considered HIV-negative. San
Francisco patients were classified as gay if they
were male and had identified themselves as gay
or bisexual during telephone interviews. Recent
sexual contact for San Francisco patients was
assessed during the telephone interviews and
was defined as having had a sexual encounter
within 10 days of the onset of shigellosis
symptoms. Foreign travel exposure was defined
as travel to an area where shigellosis was
endemic 7 days before the onset of symptoms.
Postcensus data for San Francisco and
Alameda Counties were obtained for 1996 (13).
Estimates of the prevalence of HIV infection in
San Francisco by groups at risk were obtained
from the 1997 HIV Consensus Report on HIV
Prevalence and Incidence in San Francisco (14).
This report is based on the findings of a
consensus panel that systematically reviewed
numerous sources of published and unpublished
data. FoodNet incidence rates for culture-
confirmed cases of shigellosis were based on
aggregated data collected by active laboratory-
based surveillance during 1996 in four urban
areas in Connecticut, Georgia, Minnesota, and
Oregon (15). National incidence rates were based
on culture-confirmed cases of shigellosis re-
ported through passive laboratory-based surveil-
lance in 1996 (15).
Data were managed and analyzed by Stata
4.0 (Stata Corporation, College Station, TX) and
EpiInfo 6.04b (CDC, Atlanta, GA) software.
Univariate analyses of proportions were per-
formed by chi-square test. Incidence rates and
incidence rate ratios were compared by using the
exact method to calculate confidence intervals
and statistical significance. Temporal trends of
shigellosis were assessed by conducting chi-
square for trend analysis on the number of cases
of shigellosis diagnosed by month.
During 1996, 228 and 140 culture-confirmed
cases of shigellosis were identified in San
Francisco and Alameda, respectively. In San
Francisco, 142 (62%) of these cases were caused
by S. sonnei, 73 (32%) by S. flexneri, 7 (3%) by
S. boydi, 2 (1%) by S. dysenteriae, and 4 (2%)
were not speciated. In Alameda, 93 (66%) of the
cases were caused by S. sonnei, 28 (20%) by
S. flexneri, 6 (4%) by S. boydi, 2 (2%) by
S. dysenteriae, and 11 (8%) were not speciated.
No difference was observed in the proportion of
cases caused by different species in the two
counties (p = 0.16).
An analysis of the month of diagnosis for all
patients with S. sonnei infections demonstrated
a distinct trend in both San Francisco (p = .001)
and Alameda (p = .03). The number of infections
per month was highest in San Francisco between
January and May and in Alameda between
August and November. No temporal trend was
apparent for S. flexneri infections in San
Francisco (p = .77) or Alameda (p = .36).
San Francisco patients were significantly
more likely than Alameda patients to be male,
adult, white, and HIV-infected (Table 1). Sixty-
six (39%) of 168 shigellosis patients and 30 (54%)
of 56 S. flexneri-infected patients in San
Francisco were HIV-infected; 11 (15%) of 75 HIV-
negative patients and 1 (2%) of 56 HIV-infected
patients in San Francisco reported recent travel
to a shigella-endemic area outside the United
States (p = 0.01).
The annual incidence rates of shigellosis for
various population groups in San Francisco,
Alameda, other FoodNet sites, and the United
States are shown in Table 2. San Francisco had
higher overall rates, particularly among men
and persons ages 25 to 64 years, than Alameda,
other FoodNet sites, and the United States.
In San Francisco, an analysis of the annual
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Table 2. Annual incidence rates of culture-confirmed
shigellosis per 100,000 population for selected groups,
1996
    San
Francisco Alameda FoodNet United
Group   County  County    sitesa  States
Overall rate 30.9 10.5b   7.3   5.3
Male 43.2   9.2b   7.4   3.3
Female 19.1 11.8b   7.1   3.9
Age groups
    (yrs)
<5 82.5 47.9b 36.7 16.7
  5-14 22.1 17.1 12.6   6.8
15-24 19.9   9.3b   5.3   2.4
25-39 49.9   7.6b   5.6   2.7
40-64 25.9   3.3b   2.4   1.0
65+   2.5   4.0   1.5   0.7
aDoes not include California.
bComparison of rates in San Francisco and Alameda
Counties, p value <.05.
population by sexual orientation and HIV status
showed rates of 12.4 in heterosexual and HIV-
negative persons, 60.1 in gay and HIV-negative
persons, 378 in not gay and HIV-infected
persons, and 442 in gay and HIV-infected
persons. Incidence rate ratios for these groups,
relative to the not gay and HIV-negative
population, were as follows: gay and HIV-
negative 4.9 (95% CI 2.7-8.1); not gay and HIV-
infected 30.6 (95% CI 12.8-63.0); and gay and
HIV-infected 35.7 (95% CI 25.1-50.4).
Thirty-four (10%) of 341 of patients were
hospitalized for shigellosis (median hospital stay
3 days). Furthermore, in San Francisco 13 (22%)
of 60 HIV-infected shigellosis patients were
hospitalized, while 7 (8%) of 86 HIV-negative
persons were hospitalized (p = .02). Twelve (13%)
of 93 S. flexneri and 19 (9%) of 216 S. sonnei
patients were hospitalized (p = .27).
These population-based data demonstrate a
high overall annual incidence rate of shigellosis
in San Francisco compared with neighboring
Alameda County, other FoodNet sites, and the
United States, and dramatically elevated rates
in HIV-infected San Francisco residents. The
high proportion of cases in San Francisco in both
the gay and the HIV-infected populations
suggests that these groups play a major role in
the epidemiologic features of endemic shigellosis
in San Francisco. Furthermore, the greatly
elevated incidence rates of shigellosis in the HIV-
infected population suggest that HIV may be a
important risk factor for Shigella infection.
These data also demonstrate that shigellosis is
associated with extensive illness and increased
health-care expenditures, particularly in the
HIV-infected population, as evidenced by the
frequency of hospitalization in these persons.
There are several possible explanations for
the high rates of shigellosis observed in HIV-
infected patients in this study. The compromised
host immunity of HIV-infected persons may
increase their risk for clinical infection after
exposure. A recent study found that 75% of
asymptomatic household contacts of symptom-
atic shigellosis patients had evidence of Shigella
infection by polymerase chain reaction, which
suggests that host immunity may play an
important role in determining which exposed
persons progress to clinical infection (16).
Increased susceptibility to shigellosis among
HIV-infected persons could be mediated through
different mechanisms, including compromised
cell-mediated immunity or achlorhydria. Alter-
natively, the high rate of shigellosis in HIV-
infected patients may be related to factors other
than host immunity, such as sexual or
behavioral practices, which were not thoroughly
investigated in our study.
Our investigation suggests that HIV infec-
tion is an important risk factor for shigellosis.
This finding has not been previously described
on a population level. This investigation also
suggests that HIV infection is an important
determinant of the epidemiologic features of
shigellosis in San Francisco and that public
health prevention strategies in areas with a
large HIV-infected and gay male population may
need to be revisited. A diagnosis of shigellosis in
young adult men who are not part of a recognized
outbreak and have not recently traveled to a
Shigella-endemic area may serve as a marker for
HIV infection and may indicate a need for
counseling and HIV testing.
Due to the methods of data collection,
misclassification of HIV infection status and
sexual orientation could have occurred in either
shigellosis patients or in the San Francisco
Department of Public Health population esti-
mates, thereby altering the incidence rates in an
unpredictable manner. Moreover, the propensity
of HIV-infected patients with shigellosis to seek
medical attention and the likelihood of their
health-care providers to obtain cultures may
differ from that of HIV-negative patients. This
bias, if present, could influence the observed risk823 823 823 823 823 Vol. 5, No. 6, November–December 1999 Emerging Infectious Diseases
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associated with HIV infection. However, it is
unlikely that such a bias could account for the
entire difference between groups, given the
magnitude of the elevation in incidence rates in
the HIV-infected population.
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